COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Diagnosis of Helicobacter pylori infection: Progress and challenges
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Editorial
Diagnosis of Helicobacter pylori infection: Progress and challenges
Diagnóstico de la infección por Helicobacter pylori: progresos y desafíos
Laura Llorca-Oteroa, Carlos Toro-Ruedab,
Corresponding author
carlos.toro@salud.madrid.org

Corresponding author.
a Hospital Vithas Valencia 9 de Octubre, Valencia, Spain
b Servicio de Microbiología. Hospital Universitario La Paz-Cantoblanco-Carlos III, Madrid, Spain
Read
3608
Times
was read the article
989
Total PDF
2619
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2020.09.008
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 51 31 82
2024 March 96 33 129
2024 February 73 33 106
2024 January 109 39 148
2023 December 80 50 130
2023 November 120 42 162
2023 October 123 40 163
2023 September 93 26 119
2023 August 41 10 51
2023 July 44 76 120
2023 June 45 10 55
2023 May 87 16 103
2023 April 55 4 59
2023 March 54 9 63
2023 February 46 19 65
2023 January 27 9 36
2022 December 21 14 35
2022 November 39 15 54
2022 October 32 17 49
2022 September 30 14 44
2022 August 31 19 50
2022 July 37 14 51
2022 June 16 12 28
2022 May 36 14 50
2022 April 41 15 56
2022 March 56 24 80
2022 February 40 10 50
2022 January 45 16 61
2021 December 76 22 98
2021 November 66 28 94
2021 October 301 23 324
2021 September 42 15 57
2021 August 40 15 55
2021 July 48 19 67
2021 June 68 17 85
2021 May 34 13 47
2021 April 2 1 3
2021 March 3 0 3
2021 February 6 2 8
2021 January 9 4 13
2020 December 29 22 51
2020 November 327 173 500
2020 October 0 4 4
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Executive summary of the consensus document on the shared...
Enferm Infecc Microbiol Clin. 2024;42:102-7
Executive Summary of the Consensus Statement of the Spanish...
Enferm Infecc Microbiol Clin. 2020;38:283-8
SARS-CoV-2 infection as trigger multisystem inflammatory...
Enferm Infecc Microbiol Clin. 2021;39:262-4


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos